RGX

May 07, 2020

REGENXBIO Reports First Quarter 2020 Financial Results and Operational Highlights

Feb 26, 2020

REGENXBIO Reports Fourth Quarter and Full-Year 2019 Financial Results and Operational Highlights

Jan 09, 2020

REGENXBIO Reports Continued Progress Across Programs in Year-End 2019 Corporate Update

Jul 18, 2019

Industrial Scientific Introduces the RGX(TM) Gateway Globally

May 07, 2019

REGENXBIO Reports First Quarter 2019 Financial and Operating Results and Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD

Feb 27, 2019

REGENXBIO Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Operational Highlights

Jan 03, 2019

REGENXBIO Reports Continued Progress Across Programs in Year-End 2018 Corporate Update

Nov 07, 2018

REGENXBIO Reports Third Quarter 2018 Financial and Operating Results and Announces Initiation of Phase I/II Clinical Trial for RGX-121 for the Treatment of MPS II

Aug 30, 2018

REGENXBIO Announces Pipeline Expansion with RGX-181 Gene Therapy for CLN2 Form of Batten Disease

May 08, 2018

REGENXBIO Reports First Quarter 2018 Financial Results and Recent Operational Highlights